Development and validation of a digital PCR assay targeting plasma FAR1 methylation for early detection of hepatocellular carcinoma
Open Access
- 20 April 2026
- journal article
- research article
- Published by Taylor & Francis in Epigenetics
- Vol. 21 (1) , 2653956
Abstract
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, yet current surveillance with alpha-fetoprotein (AFP) and ultrasound (US) lacks sufficient accuracy, particularly for early-stage disease. This study aimed to develop and clinically validate a blood-based digital PCR (dPCR) assay targeting novel methylation biomarkers for HCC detection. Genome-wide methylation profiles from HCC, normal, and other cancer types were analysed to identify candidates, which were then screened and verified in cancer cell lines, primary tumour tissues, and plasma specimens. A total of 186 plasma samples were evaluated, including 66 healthy controls, 60 patients with chronic liver disease (CLD) without HCC, and 60 patients with HCC. FAR1 methylation emerged as an HCC-specific biomarker, showing significantly higher levels in liver cancer cell lines and HCC tumour tissues compared with controls. A dPCR assay targeting FAR1 achieved 70.0% sensitivity (42/60; 95% CI, 56.8%–81.2%) and 96.8% specificity (122/126; 95% CI, 92.1–99.1%), with an area under the curve (AUC) of 0.90 (95% CI, 0.85–0.96). Combining FAR1 with AFP improved sensitivity to 88.3% (53/60; 95% CI, 77.4%–95.2%) while maintaining 96.8% specificity. Notably, early-stage HCC (Barcelona Clinic Liver Cancer [BCLC] stage 0–A) was detected with 85.4% sensitivity (35/41; 95% CI, 77.4%–94.4%). This blood-based dPCR assay demonstrated high diagnostic performance, underscoring its potential as a noninvasive tool to enhance early detection and clinical management of HCC in high-risk populations.Keywords
This publication has 32 references indexed in Scilit:
- Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysisGastroenterology, 2018
- Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinomaNature Materials, 2017
- Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosisAlimentary Pharmacology & Therapeutics, 2016
- Measuring Digital PCR Quality: Performance Parameters and Their OptimizationPLOS ONE, 2016
- Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with CirrhosisAmerican Journal of Gastroenterology, 2015
- ChAMP: 450k Chip Analysis Methylation PipelineBioinformatics, 2013
- Genome-Wide Methylation Analysis and Epigenetic Unmasking Identify Tumor Suppressor Genes in Hepatocellular CarcinomaGastroenterology, 2013
- Alpha-fetoprotein: A controversial prognostic biomarker for small hepatocellular carcinomaWorld Journal of Gastroenterology, 2013
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular CarcinomaGastroenterology, 2009